Carregant...
The Impact of Systemic Therapy Following Ductal Carcinoma In Situ
Following local therapy for ductal carcinoma in situ (DCIS), tamoxifen reduces the risk of ipsilateral and contralateral breast cancer by 30%–50%. Studies of tamoxifen in women with resected DCIS have not shown any effect on overall or cancer-specific survival. The adverse event profile of tamoxifen...
Guardat en:
| Publicat a: | J Natl Cancer Inst Monogr |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2010
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4999067/ https://ncbi.nlm.nih.gov/pubmed/20956830 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jncimonographs/lgq021 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|